RADAR-AD is a collaborative research initiative that explores the potential of mobile and digital technologies to improve the assessment of Alzheimer’s disease (AD). The AD terminology in the RADAR-AD project reflects the recent conceptualisation of AD as covering the full spectrum of the disease, including both pre-dementia (preclinical and prodromal AD) and dementia phases (mild to severe AD dementia).
RADAR-AD builds on the knowledge and experience gained in a sister project called RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System), which was launched in 2016 and is exploring remote monitoring in people living with multiple sclerosis, epilepsy and depression.
The RADAR-AD project has received support from the Innovative Medicines Initiative Joint Undertaking (JU) under grant agreement n° 806999. The JU receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA.
